EP2266572
pyrimidylaminobenzamide derivative for use in the treatment of a TEL-PDGFRß-induced myeloproliferative disease
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.5.2006EP published:
21.9.2016EP application number:
10173672.6
EPO information:
European Patent Register
Max expiry date:
1.5.2026
Title:
pyrimidylaminobenzamide derivative for use in the treatment of a TEL-PDGFRß-induced myeloproliferative disease
Timeline
Today
2.5.2006EP application
21.9.2016EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Manley, Paul W.Address:
Basel, CH
Name:
Mestan, JuergenAddress:
Denzlingen, DE
Name:
Fabbro, DorianoAddress:
Basel, CH
Priority
Number:
676751 PDate:
2.5.2005Country:
US
Classification
Categories:
A61K 31/506, A61P 7/00, A61P 35/02